Published in J Invest Dermatol on December 01, 2000
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. J Clin Oncol (2011) 2.87
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A (2006) 1.84
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer (2006) 1.67
Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol (2004) 1.42
Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer (2009) 1.39
Cancer biomarker discovery: the entropic hallmark. PLoS One (2010) 1.26
Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol (2006) 1.10
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol (2006) 1.07
Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro Oncol (2007) 1.04
Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells. PLoS One (2011) 1.02
Neuropilins: expression and roles in the epithelium. Int J Exp Pathol (2012) 0.98
Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo. Neoplasia (2009) 0.98
Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors. Cancer Res (2008) 0.96
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma. Mol Cancer (2010) 0.91
Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. BJOG (2012) 0.90
Neuropilins: a new target for cancer therapy. Cancers (Basel) (2011) 0.90
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung. PLoS One (2013) 0.88
The role of VEGF in melanoma progression. J Res Med Sci (2012) 0.85
Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. Cancer Res (2011) 0.84
Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery. Surg Endosc (2009) 0.83
Neuropilin-1 as Therapeutic Target for Malignant Melanoma. Front Oncol (2015) 0.83
Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth. Nutrients (2016) 0.80
ERK1/2 and AKT are vital factors in regulation of the migration of rat Schwann cells. J Vet Med Sci (2015) 0.78
NAADP-Dependent Ca(2+) Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis. Sci Rep (2016) 0.77
The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells. Biochem J (2013) 0.77
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy. Int J Mol Sci (2015) 0.77
Targeted therapy in melanoma. Biologics (2009) 0.76
Neuropilin-1 in transplantation tolerance. Front Immunol (2013) 0.75
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding. Oncotarget (2016) 0.75
Metastatic melanoma positively influences pregnancy outcome in a mouse model: could a deadly tumor support embryo life? Clin Exp Metastasis (2007) 0.75
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. Oncotarget (2017) 0.75
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. J Exp Clin Cancer Res (2017) 0.75
Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol (1998) 1.83
Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol (2000) 1.81
Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities. Hum Mol Genet (1998) 1.69
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation (1999) 1.67
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration. Br J Dermatol (2014) 1.40
Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol (1993) 1.39
A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest (1997) 1.35
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res (1981) 1.29
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther (2002) 1.26
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp (2007) 1.25
The role of CSA in the response to oxidative DNA damage in human cells. Oncogene (2007) 1.25
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol (1994) 1.18
Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol (2010) 1.16
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol (2001) 1.16
Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology (2007) 1.09
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis (2012) 1.05
Quality of life in patients with epidermolysis bullosa. Br J Dermatol (2009) 1.04
Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes. Cancer Res (2001) 1.04
A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother (1998) 1.02
Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1993) 1.02
The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp Parasitol (1995) 1.00
Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. Mol Pharmacol (1997) 0.99
Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol (2000) 0.99
Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. Development (1993) 0.98
Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens (2004) 0.97
Pseudomonas aeruginosa nitrite reductase (or cytochrome oxidase): an overview. Biochimie (1994) 0.97
Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1994) 0.96
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol (1994) 0.96
Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol (2006) 0.96
Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol (2003) 0.96
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94
Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene (2009) 0.93
Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine. J Neurol Neurosurg Psychiatry (2006) 0.93
Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Proc Natl Acad Sci U S A (2001) 0.93
Apoptosis and efficient repair of DNA damage protect human keratinocytes against UVB. Cell Death Differ (2003) 0.93
Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther (1998) 0.93
Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol (1989) 0.93
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis. Cell Death Dis (2012) 0.91
New type of epidermal nevus syndrome. Dermatology (2000) 0.91
Antioxidant status in various tissues of the mouse after fasting and swimming stress. Eur J Appl Physiol Occup Physiol (1997) 0.91
Processing of GB virus B non-structural proteins in cultured cells requires both NS3 protease and NS4A cofactor. J Gen Virol (2000) 0.90
Involucrin expression in keratinization disorders of the skin--a preliminary study. Br J Dermatol (1987) 0.90
An automatic classification technique for attenuation correction in positron emission tomography. Eur J Nucl Med (1999) 0.90
Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology (2001) 0.89
In vitro infection of human epidermal Langerhans' cells with HIV-1. Immunology (1995) 0.89
Lethal autosomal recessive epidermolytic ichthyosis due to a novel donor splice-site mutation in KRT10. Br J Dermatol (2010) 0.89
Uptake of exogenous DNA by mammalian spermatozoa: specific localization of DNA on sperm heads. J Reprod Fertil (1992) 0.88
Association of piebaldism and neurofibromatosis type 1 in a girl. Pediatr Dermatol (2002) 0.88
Genomic structure, promoter characterisation and mutational analysis of the S100A7 gene: exclusion of a candidate for familial psoriasis susceptibility. Hum Genet (1999) 0.88
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer (1998) 0.87
Induction of senescence pathways in Kindler syndrome primary keratinocytes. Br J Dermatol (2013) 0.87
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol (1994) 0.86
Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry (2004) 0.86
Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa. Biochem Biophys Res Commun (1998) 0.86
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa. Hum Gene Ther (2000) 0.85
Beta 1 and beta 3 integrin upregulation in rapidly progressive glomerulonephritis. Nephrol Dial Transplant (1995) 0.85
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. Mult Scler (2013) 0.84
Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma. Br J Dermatol (2007) 0.84
Cisplatin increases sensitivity of human leukemic blasts to triazene compounds. J Chemother (1995) 0.84
The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation. Br J Dermatol (2010) 0.84
A glutamine insertion in the 1A alpha helical domain of the keratin 4 gene in a familial case of white sponge nevus. J Invest Dermatol (2000) 0.84
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia (1999) 0.84
Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy. Ital J Neurol Sci (1996) 0.84
Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression. Br J Dermatol (2011) 0.83
Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition. J Invest Dermatol (2001) 0.83
Delayed diagnosis of dyskeratosis congenita in a 40-year-old woman with multiple head and neck squamous cell carcinomas. Br J Dermatol (2007) 0.83
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet (2004) 0.83
Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol (2011) 0.83
Circumscribed palmo-plantar hypokeratosis: a disease of desquamation? Immunohistological study of five cases and literature review. J Eur Acad Dermatol Venereol (2011) 0.83
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin Exp Rheumatol (2006) 0.82
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol (2011) 0.82
Expression of neural-tissue markers (S-100 protein and Leu-7 antigen) by sweat gland tumors of the skin. An immunohistochemical study. J Am Acad Dermatol (1987) 0.82
In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds. J Pharmacol Exp Ther (1996) 0.82
Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1998) 0.82
Beta-1 integrins in the normal human glomerular capillary wall: an immunoelectron microscopy study. Nephron (1994) 0.82
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol (2004) 0.82
Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in the type VII collagen gene. Br J Dermatol (2002) 0.82
Eccrine syringofibroadenoma. Immunohistological study of a new case. Am J Dermatopathol (1987) 0.81
Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes. J Immunol (1997) 0.81
O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity. J Pharmacol Exp Ther (1999) 0.81
Human epidermal basal keratinocytes express CDw29 antigens. Br J Dermatol (1989) 0.81
Free radical production during metabolism of organic hydroperoxides by normal human keratinocytes. J Invest Dermatol (1993) 0.81
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study. Arch Dermatol (1992) 0.81